Android app on Google Play

Cell Therapeutics (CTIC) Sees Momentum Run-Up

January 8, 2013 10:11 AM EST Send to a Friend
Momentum traders are all over Cell Therapeutics, Inc. (NASDAQ: CTIC) Tuesday following Peregrine Pharmaceuticals' (NASDAQ: PPHM) 80% surge yesterday.

Shares of CTIC last traded at up 25% to $1.63. Volume is already more than 3x the full day norm.




You May Also Be Interested In


Related Categories

Momentum Movers

Add Your Comment